Aptose Biosciences Inc. (TSX:APS)
2.190
+0.030 (1.39%)
At close: Mar 6, 2026
Aptose Biosciences Employees
Aptose Biosciences had 13 employees as of December 31, 2024. The number of employees decreased by 23 or -63.89% compared to the previous year.
Employees
13
Change (1Y)
-23
Growth (1Y)
-63.89%
Revenue / Employee
n/a
Profits / Employee
-2.07M CAD
Market Cap
5.59M
Employees Chart
Aptose Biosciences News
- 11 months ago - Aptose Announces Auditor Not Standing for Re-Appointment - GlobeNewsWire
- 11 months ago - Aptose to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference - GlobeNewsWire
- 1 year ago - Aptose Reports Year End 2024 Results and Corporate Highlights - GlobeNewsWire
- 1 year ago - Aptose Biosciences Meets Nasdaq Minimum Bid Price Compliance - GlobeNewsWire
- 1 year ago - Why Is Penny Stock Aptose Biosciences Trading Higher On Thursday? - Benzinga
- 1 year ago - Aptose Announces Positive Clinical Safety Review Committee (CSRC) Approval to Dose Escalate in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy with Tuspetinib Amid Complete Responses and Favorable Safety in First Cohort - GlobeNewsWire
- 1 year ago - Aptose Announces Reverse Share Split - GlobeNewsWire
- 1 year ago - Aptose Enters into $25 Million Committed Equity Facility and Establishes New At-The-Market Facility - GlobeNewsWire